Dr Reddy’s, Fujifilm JV by March 2012

23 November 2011: Drug maker Dr Reddy’s Laboratories is likely to sign an agreement with image processing and photography technology company Fujifilm by the fiscal end for a foray into the Japanese generics market. The new company will develop, manufacture and promote generic drugs, utilising both Fujifilm’s advanced quality control technologies it has built up through its photo film business and Dr Reddy’s expertise in cost competitive production technologies for active pharmaceutical ingredients (APIs) and formulations gained over the years by supplying to markets globally.

Though nitty-gritty of the deal is still being worked out, Dr Reddy’s is looking at a three-year timeframe to gain full traction in that country. Tokyo-headquartered Fujifilm has an exclusive partnership with Dr Reddy’s in the generics business.
The venture intends to launch its first products in Japan in the next three to four years and also to design products that fit the specific requirements of that market.

Source: DNA